M
Mitotech at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Mitotech brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program centres on SkQ1, a compound that raises energy expenditure through fatty acid-dependent uncoupling, tested in diet-induced obese mice. One study reports SkQ1 matching the weight loss of semaglutide while food intake is preserved.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
M Mitotech | |
Drug developer of SkQ1, a compound studied here for energy expenditure and weight loss. | Poster Sat Nov 14 7:30pm–8:30pm SkQ1, a Free Fatty Acid–Dependent Uncoupling Accelerator, Increases Energy Expenditure and Reduces Food Intake in Diet-Induced Obese Mice Metabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm SkQ1, an FFA-Gated EE Accelerator, Matches Semaglutide Weight Loss with Preserved Food Intake Metabolism and integrative physiology |
Find decision makers at Mitotech
Tell us what you sell and we’ll find the people at Mitotech most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction